8-K/A
filed May 30, 2024, 7:59 PM ET
ticker PHGE
CIK 0001739174
other material
confidence high
sentiment negative
materiality 0.80
BiomX files APT financials: net loss $16M, going concern doubt
BiomX Inc.
- APT net loss of $16.0M in 2023 and $23.6M in 2022; accumulated deficit $67.3M at Dec 31, 2023.
- APT revenue $14.1M in 2023 vs $5.9M in 2022 from government grants; cash only $1.3M.
- Auditor's report includes going concern emphasis; current cash insufficient for 12 months.
- APT issued $12.0M of Series B-1 preferred in 2023 but needs additional financing.
- Financials filed to complete previously reported acquisition of APT by BiomX.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-24-048040
- form_type
- 8-K/A
- ticker
- PHGE
- cik
- 0001739174
- company_name
- BiomX Inc.
- filed_at
- 2024-05-30T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:19.833346+00:00
- generated_at
- 2026-06-01T07:26:07.261581+00:00
- sec_items
- ["9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.8
- calibrated_materiality_score
- 0.8
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-24-048040
- json_url
- https://secwatch.observer/filing/0001213900-24-048040.json
- markdown_url
- https://secwatch.observer/filing/0001213900-24-048040.md
- text_url
- https://secwatch.observer/filing/0001213900-24-048040.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1739174/000121390024048040/0001213900-24-048040-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1739174/000121390024048040/ea0207019-8ka1_biomx.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
KRMN
Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds
Karman Holdings Inc.
June 1, 2026, 5:28 PM ET
other_material
Items 1.01, 7.01, 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
AII
American Integrity fully places 2026-2027 CAT XOL reinsurance with $2.99B total limit
American Integrity Insurance Group, Inc.
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CSR
Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City
CENTERSPACE
June 1, 2026, 4:30 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LBTYA
Liberty Global names Stephen van Rooyen as Ziggo Group CEO; plans Amsterdam listing in 2027
Liberty Global Ltd.
June 1, 2026, 4:07 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
IDYA
IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma
IDEAYA Biosciences, Inc.
June 1, 2026, 4:05 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
FULC
Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review
Fulcrum Therapeutics, Inc.
June 1, 2026, 4:05 PM ET
other_material
Items 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MDAI
Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026
Spectral AI, Inc.
June 1, 2026, 4:01 PM ET
other_material
Items 5.07, 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.